Savara
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.About SVRA
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis.
CEOMatthew Pauls
CEOMatthew Pauls
Employees59
Employees59
HeadquartersLanghorne, Pennsylvania
HeadquartersLanghorne, Pennsylvania
Founded1995
Founded1995
Employees59
Employees59
SVRA Key Statistics
Market cap1.24B
Market cap1.24B
Price-Earnings ratio-11.83
Price-Earnings ratio-11.83
Dividend yield—
Dividend yield—
Average volume4.11M
Average volume4.11M
High today$6.36
High today$6.36
Low today$6.00
Low today$6.00
Open price$6.32
Open price$6.32
Volume2.03M
Volume2.03M
52 Week high$7.01
52 Week high$7.01
52 Week low$1.89
52 Week low$1.89
Stock Snapshot
Savara(SVRA) stock is priced at $6.11, giving the company a market capitalization of 1.24B. It carries a P/E multiple of -11.83.
During the trading session on 2025-12-30, Savara(SVRA) shares reached a daily high of $6.36 and a low of $6.00. At a current price of $6.11, the stock is +1.9% higher than the low and still -3.9% under the high.
Trading volume for Savara(SVRA) stock has reached 2.03M, versus its average volume of 4.11M.
The stock's 52-week range extends from a low of $1.89 to a high of $7.01.
The stock's 52-week range extends from a low of $1.89 to a high of $7.01.
SVRA News
Simply Wall St 5d
Savara: Reassessing Valuation After MOLBREEVI BLA Resubmission and Priority Review RequestSavara (SVRA) just took a key regulatory step by resubmitting its Biologics License Application for MOLBREEVI and asking the FDA for Priority Review, a move tha...
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SVRA. This list is generated using Robinhood data, and it’s not a recommendation.